Frontiers in Oncology (Feb 2022)
Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway
- Dongli Yue,
- Dongli Yue,
- Daiqun Zhang,
- Xiaojuan Shi,
- Shasha Liu,
- Anqi Li,
- Dong Wang,
- Dong Wang,
- Guohui Qin,
- Guohui Qin,
- Yu Ping,
- Yamin Qiao,
- Yamin Qiao,
- Xinfeng Chen,
- Xinfeng Chen,
- Feng Wang,
- Renyin Chen,
- Song Zhao,
- Lidong Wang,
- Yi Zhang,
- Yi Zhang,
- Yi Zhang
Affiliations
- Dongli Yue
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Dongli Yue
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Daiqun Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xiaojuan Shi
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Shasha Liu
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Anqi Li
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Dong Wang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Dong Wang
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Guohui Qin
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Guohui Qin
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Yu Ping
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Yamin Qiao
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Yamin Qiao
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xinfeng Chen
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xinfeng Chen
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Feng Wang
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Renyin Chen
- Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Song Zhao
- Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Lidong Wang
- Henan Key Laboratory for Esophageal Cancer Research and State Key Laboratory for Esophageal Cancer Prevention & Treatment of The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Yi Zhang
- Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Yi Zhang
- School of Life Sciences, Zhengzhou University, Zhengzhou, China
- Yi Zhang
- Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, China
- DOI
- https://doi.org/10.3389/fonc.2022.860158
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
